Liquid Dosage
As a result of growing competition and more stringent regulatory requirements for end-user safety, improving the convenience and ease of administration of parenteral therapeutics is becoming a common strategy for biotechnology and pharmaceutical companies. Manufacturers wishing to gain market share and provide high quality products for healthcare professionals and cancer patients alike are increasingly investing in the development and delivery of liquid dosage forms, freeze-dried products and injectables.
GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. We perform tests and trial runs with appropriate media to demonstrate the functionality of all components and equipment before the plant is delivered.
In collaboration and partnership with our customers, we aim to develop and deliver high-performance plant and economic process systems that comply with the highest operational safety and environmental standards; we want our customers to use our groundbreaking solutions to manufacture even better products in the future.
GEA can supply a specialized, contained and fully integrated system when no standard off-the-shelf one exists, particularly for toxic or highly potent drugs such as cytostatics or echo contrast media. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.
Visualizzazione di 4 su 8

GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.

GEA Hilge offre una gamma versatile di pompe centrifughe e volumetriche per un'ampia varietà di applicazioni sensibili nell'industria delle bevande, alimentare e farmaceutica.

GEA's versatile range of R&D drying & particle processing equipment - for advanced powder processing within food and dairy products, chemicals and pharmaceuticals.

I separatori di GEA sono progettati per applicazioni a base liquida. Utilizzano la forza centrifuga per separare sospensioni composte da due o più fasi di densità diverse; possono cioè essere utilizzati per la separazione liquido-liquido, la separazione liquido-liquido-solido o la separazione liquido-solido. Separano miscele liquide con la stessa...
Negli allevamenti vige una regola semplice ma fondamentale: gli zoccoli devono essere sani. Quando questo presupposto viene meno, le prestazioni, il benessere e l'efficienza ne risentono immediatamente, a prescindere da quanto all'avanguardia possa essere l'azienda.
Together with Mona Neubaur, Minister of Economic Affairs of the German state of North Rhine-Westphalia, GEA CEO Stefan Klebert has opened a new technology center for pharmaceutical freeze-drying systems in Elsdorf, Germany. GEA employs approximately 260 people at the facility, which combines research and development with production and service under one roof.